Important Alerts
Updates

Effective May 5, 2025, Podiatry in West New York will relocate to 201 State Rt 17 in Rutherford.

Effective April 28, 2025, Primary Care in Haddon Heights will relocate to 2 South Black Horse Pike in Mt. Ephraim.

Effective April 28, 2025, Cardiology in Haddon Heights will relocate to 322 Route 38, Cherry Hill.

Effective April 21, 2025 Pediatrics – Wall at 1560 State Route 138 will relocate to 3350 State Route 138.

Effective April 14, 2025 Primary Care – Voorhees has relocated to 165 S Black Horse Pike, Runnemede.

Effective April 14, 2025  Pediatrics – Manasquan has relocated to  3350 State Route 138 Wall.

As of April 7, 2025, Podiatry in Bayonne has relocated to 191 Lefante Way, Suite C in Bayonne.

As of April 7, 2025  Gastroenterology – Hackensack and Cardiology – Hackensack have relocated to 1 Maywood Avenue in Maywood.

As of April 7, 2025 Primary Care – Moorestown and Cardiology – Moorestown have relocated to Cherry Hill at 322 Route 38, Cherry Hill.

As of April 7,  2025,  Primary Care – Secaucus  and Gastroenterology – Secaucus have relocated to Rutherford at 201 Route 17 11th Floor Rutherford.

As of March 31, 2025, Primary Care – Rutherford has relocated to 201 Route 17, Suite 1102 in Rutherford.

As of March 28, 2025,  Primary Care – Roslyn has relocated to the Optum multi-specialty medical office location in Lake Success.

As of March 3, 2025, Pediatrics – Port Jefferson has relocated to 1500 Route 112, Building 1, Floor 1, in Port Jefferson.

As of March 3, 2025, Primary Care – Port Jefferson Station has relocated to 1500 Route 112, Building 1, Floor 1, in Port Jefferson.

Recording/Photography Not Permitted on Premises

Office and Urgent Care Closures

Long Beach Urgent care will close at 1 pm, today Monday April 14. We will reopen Tuesday April 15, for normal operating hours.

Plainview Urgent care will be closed, Sunday April 13, and Monday April 14, and will reopen Tuesday April 15,  for normal operating hours.

The Croton-on-Hudson lab is temporarily closed until further notice.

COVID-19 Information and Updates
View all

Understanding cervical cancer

21 December, 2024
Produced by:
$author_name
Optum Medical Care, P.C.
Understanding cervical cancer

Understanding cervical cancer

While still a significant health issue, cervical cancer has become less common as a leading cause of cancer-related death among women in the United States, largely due to preventive screening efforts. According to the CDC, about 11,500 new cases of cervical cancer are reported in the United States each year, and about 4,000 deaths. These numbers have decreased over the years, highlighting the importance of regular screenings, such as Pap tests, which help catch cervical abnormalities or cancer early, and HPV tests, which screen for human papillomavirus—the virus most likely to cause cervical cancer.

Prevention

Cervical cancer prevention starts with regular screenings. A Pap test and/or HPV test, conducted during routine exams, can identify cervical changes that may lead to cancer. These screenings allow health care providers to catch and treat any precancerous cells early, reducing the risk of developing cervical cancer. The HPV vaccine is another powerful preventive measure, providing protection against the HPV strains most likely to lead to cervical cancer. Additional protective steps include safe sexual practices, limiting the number of sexual partners, and avoiding smoking.

Common signs and symptoms

Women with early cervical cancers and pre-cancers usually have no symptoms. Cervical cancer symptoms may not be noticeable until the cancer has spread beyond the cervix. The most common early symptoms can include abnormal vaginal bleeding, pain during sex, bleeding after menopause or unusual vaginal discharge. In more advanced stages, signs may include swollen legs, blood in urine, or difficulties with bowel movements or urination. These symptoms are not unique to cervical cancer but should prompt a medical evaluation if they occur.

Survival rates

Survival rates for cervical cancer vary depending on the stage at diagnosis.
Localized (confined to the cervix or uterus ): 91% five-year survival rate.
Regional (spread to nearby lymph nodes): 60% five-year survival rate.
Distant (spread to other parts of the body): 19% five-year survival rate. Early diagnosis is key to improving outcomes, as these statistics emphasize.

Who is most at risk for cervical cancer?

Cervical cancer is most often diagnosed in women between 35 and 44, although certain factors increase risk. Having HIV or another condition that makes it hard for your body to fight off health problems can increase your risk of cervical cancer, along with smoking. Cervical cancer incidence rates decreased by more than half from the mid-1970s to the mid-2000s.They have stabilized over the past decade, largely due to the increased use of screening. However, in women ages 30-44, rates have increased 1.7% each year from 2012 to 2019.

While cervical cancer remains a serious concern, preventive screenings, vaccines, and early detection strategies continue to improve outcomes and lower risks, empowering women to take control of their health.

Sources:

Cervical Cancer Statistics | Cervical Cancer | CDC

https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.html

https://www.cancer.org/cancer/types/cervical-cancer/causes-risks-prevention/prevention.html

https://www.cancer.org/cancer/types/cervical-cancer/causes-risks-prevention/prevention.html

https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/signs-symptoms.html

https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/signs-symptoms.html

https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/survival.html

https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.html

https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.html